Trial
NCT07245836
Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Medical University of Vienna
Collaborators
—
Condition
Dry Eye Disease (DED)
Intervention
Thealoz Total® Eye Drops, Laboratoires Thea, Clermont Ferrand, France
Why stopped
This study was not halted prematurely. This record represents a duplicate entry and has therefore been withdrawn. The correct and complete study information can be found under identifier NCT07007702.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-08